Star Imaging and Path Lab Ltd Intrinsic Value
STARIMAGIN · Healthcare Services · Current price ₹88.78
Is Star Imaging and Path Lab Ltd undervalued?
DocStoX estimates the fair value of Star Imaging and Path Lab Ltd at ₹318 per share, versus the current market price of ₹89. That puts the stock about +257.9% below our fair-value estimate, which we read as "Strong Buy". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹171), Relative P/E (₹716), Graham floor (₹129). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹129 (bear) to ₹318 (base) to ₹716 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹89 versus an intrinsic value of ₹318, Star Imaging and Path Lab Ltd currently offers +257.9% of margin.
More on Star Imaging and Path Lab Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.